Timothy Wiltshire (Tim Wiltshire)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Chemotherapy Induced

Genome Wide Association

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics 115 (5) (2024)
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics (2024)
Spinel Karas, Ron H J Mathijssen, Ron H N van Schaik, Alan Forrest, Timothy Wiltshire, Robert R Bies, Federico Innocenti
Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model. Clinical pharmacology and therapeutics 115 (5) (2024)
Farida S Akhtari, Adrian J Green, George W Small, Tammy M Havener, John S House, Kyle R Roell, David M Reif, Howard L McLeod, Timothy Wiltshire, Allison A Motsinger-Reif
High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs. PLoS genetics 17 (8) (2021)